

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.58513713 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.98110770 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.98110770 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.97451155 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.61212775 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.05517609 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02897698 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.00542682 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.75897745 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.59982566 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52506044 |
| 12 | negative T cell selection (GO:0043383) | 4.46065601 |
| 13 | negative thymic T cell selection (GO:0045060) | 4.45595100 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44645368 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.44645368 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44645368 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44645368 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44645368 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.44645368 |
| 20 | response to interleukin-15 (GO:0070672) | 4.44270293 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.36931809 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 4.26301435 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 4.22126839 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.21025554 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.11513781 |
| 26 | detection of other organism (GO:0098543) | 4.10991715 |
| 27 | regulation of B cell differentiation (GO:0045577) | 4.04477842 |
| 28 | cellular extravasation (GO:0045123) | 3.99227583 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.95029929 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.92355089 |
| 31 | leukocyte aggregation (GO:0070486) | 3.89587661 |
| 32 | positive T cell selection (GO:0043368) | 3.87016489 |
| 33 | detection of bacterium (GO:0016045) | 3.84343423 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.82408976 |
| 35 | activated T cell proliferation (GO:0050798) | 3.80542229 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.76161130 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.75783178 |
| 38 | neutrophil activation (GO:0042119) | 3.69854699 |
| 39 | microglial cell activation (GO:0001774) | 3.68254987 |
| 40 | T cell migration (GO:0072678) | 3.68154308 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.59745985 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.59525480 |
| 43 | positive regulation of granulocyte differentiation (GO:0030854) | 3.56080725 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.54328994 |
| 45 | T cell selection (GO:0045058) | 3.49231190 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.49186951 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.46509417 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.43970506 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43447798 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41153983 |
| 51 | response to peptidoglycan (GO:0032494) | 3.38937742 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.37840761 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.35343941 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31544806 |
| 55 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.30375327 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.30375327 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30126824 |
| 58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29572237 |
| 59 | response to host immune response (GO:0052572) | 3.29572237 |
| 60 | mast cell activation (GO:0045576) | 3.29130573 |
| 61 | thymic T cell selection (GO:0045061) | 3.25525028 |
| 62 | granulocyte activation (GO:0036230) | 3.23851863 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.22588836 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22035296 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.21629048 |
| 66 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.20789773 |
| 67 | neutrophil mediated immunity (GO:0002446) | 3.18915629 |
| 68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18855669 |
| 69 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.18089812 |
| 70 | response to type I interferon (GO:0034340) | 3.17550124 |
| 71 | B cell mediated immunity (GO:0019724) | 3.17486405 |
| 72 | regulation of mast cell activation (GO:0033003) | 3.17278083 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16715785 |
| 74 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.15660517 |
| 75 | cellular response to type I interferon (GO:0071357) | 3.15516677 |
| 76 | type I interferon signaling pathway (GO:0060337) | 3.15516677 |
| 77 | leukocyte degranulation (GO:0043299) | 3.14846954 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 3.14353233 |
| 79 | detection of biotic stimulus (GO:0009595) | 3.12586081 |
| 80 | interferon-gamma production (GO:0032609) | 3.12268147 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10959684 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.08371376 |
| 83 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.08311000 |
| 84 | macrophage activation (GO:0042116) | 3.07971774 |
| 85 | tolerance induction (GO:0002507) | 3.07653850 |
| 86 | dendritic cell migration (GO:0036336) | 3.04945758 |
| 87 | respiratory burst (GO:0045730) | 3.03291085 |
| 88 | defense response to protozoan (GO:0042832) | 2.98939258 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 2.95565410 |
| 90 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95184067 |
| 91 | negative regulation of adaptive immune response (GO:0002820) | 2.95102975 |
| 92 | response to muramyl dipeptide (GO:0032495) | 2.94332888 |
| 93 | positive regulation of tolerance induction (GO:0002645) | 2.94073470 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92755182 |
| 95 | response to host (GO:0075136) | 2.92755182 |
| 96 | response to host defenses (GO:0052200) | 2.92755182 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.91158248 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.91158248 |
| 99 | germinal center formation (GO:0002467) | 2.90929975 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.88971325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32518027 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.84484974 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.63621121 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.58944775 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.10076440 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.61040004 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41506850 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.37379671 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25079400 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92423754 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.92271036 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.81507411 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72905698 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.69865228 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.43574966 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36231504 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31208145 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.20909944 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19869802 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13018899 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12015844 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.11679214 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10433774 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98301833 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94296401 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94136055 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.93708340 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88827642 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.86357332 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85346862 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85160032 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81350381 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72791904 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71038657 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70295066 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63535701 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63273540 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61475706 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55979367 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53871849 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51998656 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.47588857 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46541113 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40328053 |
| 45 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38458385 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37372488 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35708076 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30635442 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.30568960 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28366262 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28014265 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26237290 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25863801 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.25587536 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22759219 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22475543 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21785197 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19461807 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15830155 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13554808 |
| 61 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.12614240 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06554881 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03047172 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99254704 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97993068 |
| 66 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95465754 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95384120 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91167386 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90084453 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89680188 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88028270 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87166528 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86725412 |
| 74 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86306407 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85645900 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85589981 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85514903 |
| 78 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82141909 |
| 79 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81551557 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81454447 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81041308 |
| 82 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79962382 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79189980 |
| 84 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78626645 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77020862 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76743734 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76078809 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75736563 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74779534 |
| 90 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.74302629 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.73828730 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.72646169 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72179499 |
| 94 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71928677 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71667292 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.70589323 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.69385077 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69339883 |
| 99 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.68810914 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68464161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.95947938 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.15108351 |
| 3 | MP0005671_abnormal_response_to | 3.67942106 |
| 4 | MP0003436_decreased_susceptibility_to | 3.41918105 |
| 5 | MP0001800_abnormal_humoral_immune | 3.24740579 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.88985544 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.88186513 |
| 8 | MP0003303_peritoneal_inflammation | 2.86228511 |
| 9 | MP0002419_abnormal_innate_immunity | 2.79213589 |
| 10 | MP0005387_immune_system_phenotype | 2.76764786 |
| 11 | MP0001790_abnormal_immune_system | 2.76764786 |
| 12 | MP0002723_abnormal_immune_serum | 2.76271183 |
| 13 | MP0000685_abnormal_immune_system | 2.75319218 |
| 14 | MP0005025_abnormal_response_to | 2.70510161 |
| 15 | MP0009785_altered_susceptibility_to | 2.67617842 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.64073302 |
| 17 | MP0001819_abnormal_immune_cell | 2.61209663 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.60209939 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.41496708 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.32497819 |
| 21 | MP0002398_abnormal_bone_marrow | 2.18793559 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 2.07430965 |
| 23 | MP0006082_CNS_inflammation | 2.07416480 |
| 24 | MP0000716_abnormal_immune_system | 2.07160044 |
| 25 | MP0002405_respiratory_system_inflammati | 2.04957634 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.91928365 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.91197392 |
| 28 | MP0003828_pulmonary_edema | 1.89500055 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.87730335 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.85882682 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.80979448 |
| 32 | MP0002722_abnormal_immune_system | 1.78294087 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.72595023 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.70597194 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.70031022 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.68893723 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.68381902 |
| 38 | MP0003866_abnormal_defecation | 1.63895122 |
| 39 | MP0002429_abnormal_blood_cell | 1.62254821 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.62130066 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.57884943 |
| 42 | MP0009764_decreased_sensitivity_to | 1.54074192 |
| 43 | MP0004381_abnormal_hair_follicle | 1.37733089 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.35996736 |
| 45 | MP0008469_abnormal_protein_level | 1.34635520 |
| 46 | MP0002132_abnormal_respiratory_system | 1.31380970 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.29322429 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.29322429 |
| 49 | MP0005310_abnormal_salivary_gland | 1.26835981 |
| 50 | MP0009278_abnormal_bone_marrow | 1.25731326 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.24138386 |
| 52 | MP0006054_spinal_hemorrhage | 1.22763826 |
| 53 | MP0004947_skin_inflammation | 1.22492870 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.20089307 |
| 55 | MP0004883_abnormal_blood_vessel | 1.18851658 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.18406735 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.15471642 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.15102793 |
| 59 | MP0004130_abnormal_muscle_cell | 1.10395987 |
| 60 | MP0002006_tumorigenesis | 1.05498078 |
| 61 | MP0002009_preneoplasia | 1.04881339 |
| 62 | MP0001851_eye_inflammation | 1.04861580 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.03257078 |
| 64 | MP0003787_abnormal_imprinting | 1.00471553 |
| 65 | MP0001873_stomach_inflammation | 0.98731810 |
| 66 | MP0008260_abnormal_autophagy | 0.96227139 |
| 67 | MP0000015_abnormal_ear_pigmentation | 0.95515606 |
| 68 | MP0003195_calcinosis | 0.93986287 |
| 69 | MP0002998_abnormal_bone_remodeling | 0.88654248 |
| 70 | MP0004484_altered_response_of | 0.88400425 |
| 71 | MP0002933_joint_inflammation | 0.87646494 |
| 72 | MP0001663_abnormal_digestive_system | 0.86618618 |
| 73 | MP0003045_fibrosis | 0.85388338 |
| 74 | MP0001853_heart_inflammation | 0.84445202 |
| 75 | MP0000858_altered_metastatic_potential | 0.83424364 |
| 76 | MP0009763_increased_sensitivity_to | 0.82256564 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.78798520 |
| 78 | MP0000249_abnormal_blood_vessel | 0.78103345 |
| 79 | MP0005164_abnormal_response_to | 0.75244995 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.75121837 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.73866447 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.72553324 |
| 83 | MP0000343_altered_response_to | 0.70993567 |
| 84 | MP0003252_abnormal_bile_duct | 0.70173191 |
| 85 | MP0003690_abnormal_glial_cell | 0.63621078 |
| 86 | MP0002928_abnormal_bile_duct | 0.62425764 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.62305716 |
| 88 | MP0003075_altered_response_to | 0.60822677 |
| 89 | MP0005083_abnormal_biliary_tract | 0.58646976 |
| 90 | MP0005166_decreased_susceptibility_to | 0.58526433 |
| 91 | MP0005390_skeleton_phenotype | 0.56043857 |
| 92 | MP0003448_altered_tumor_morphology | 0.55218725 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.54455666 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.53775886 |
| 95 | MP0000604_amyloidosis | 0.52101313 |
| 96 | MP0008004_abnormal_stomach_pH | 0.49624161 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.48531448 |
| 98 | MP0009115_abnormal_fat_cell | 0.47014851 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.45668930 |
| 100 | MP0003795_abnormal_bone_structure | 0.45523480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 5.20532343 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.99203746 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.98617442 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.96989650 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.85082631 |
| 6 | Stomatitis (HP:0010280) | 4.73796271 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.72085152 |
| 8 | Optic neuritis (HP:0100653) | 4.72085152 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.66453610 |
| 10 | Orchitis (HP:0100796) | 4.63964936 |
| 11 | T lymphocytopenia (HP:0005403) | 4.55093196 |
| 12 | Abnormality of T cell number (HP:0011839) | 4.52069037 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.48966328 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.22701517 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 4.22701517 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 4.19955048 |
| 17 | Spontaneous hematomas (HP:0007420) | 4.08258585 |
| 18 | Encephalitis (HP:0002383) | 4.06818473 |
| 19 | Meningitis (HP:0001287) | 3.98003218 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.83600795 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.78948241 |
| 22 | Recurrent skin infections (HP:0001581) | 3.74351055 |
| 23 | Abnormality of T cells (HP:0002843) | 3.69568043 |
| 24 | Obstructive lung disease (HP:0006536) | 3.60695876 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.60695876 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56876091 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 3.55868200 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.52801446 |
| 29 | Vasculitis (HP:0002633) | 3.52035306 |
| 30 | Prolonged bleeding time (HP:0003010) | 3.46253150 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.40838848 |
| 32 | Chest pain (HP:0100749) | 3.35668691 |
| 33 | Leukocytosis (HP:0001974) | 3.35341821 |
| 34 | Recurrent viral infections (HP:0004429) | 3.29086553 |
| 35 | Hemoptysis (HP:0002105) | 3.25664698 |
| 36 | Eosinophilia (HP:0001880) | 3.15434408 |
| 37 | Agammaglobulinemia (HP:0004432) | 3.15097461 |
| 38 | Granulocytopenia (HP:0001913) | 3.14565942 |
| 39 | Pustule (HP:0200039) | 3.10038011 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.03352550 |
| 41 | Stomach cancer (HP:0012126) | 3.01297424 |
| 42 | Abnormality of eosinophils (HP:0001879) | 2.99647581 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.99244736 |
| 44 | Epistaxis (HP:0000421) | 2.98698284 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 2.92932326 |
| 46 | Gingival bleeding (HP:0000225) | 2.91630399 |
| 47 | Arterial thrombosis (HP:0004420) | 2.89897564 |
| 48 | Pulmonary embolism (HP:0002204) | 2.87316148 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.84948950 |
| 50 | IgG deficiency (HP:0004315) | 2.83932053 |
| 51 | Hypochromic anemia (HP:0001931) | 2.81388348 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.80673161 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 2.79036475 |
| 54 | Abnormality of B cell number (HP:0010975) | 2.74683975 |
| 55 | Urticaria (HP:0001025) | 2.72801958 |
| 56 | Increased IgM level (HP:0003496) | 2.66029603 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.59614542 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.56942187 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.56595023 |
| 60 | Gingivitis (HP:0000230) | 2.52212016 |
| 61 | Abnormality of the pleura (HP:0002103) | 2.48704465 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.44409352 |
| 63 | Anorexia (HP:0002039) | 2.43574424 |
| 64 | Microcytic anemia (HP:0001935) | 2.41257008 |
| 65 | Hematochezia (HP:0002573) | 2.40264974 |
| 66 | Increased IgE level (HP:0003212) | 2.37771032 |
| 67 | Cellulitis (HP:0100658) | 2.33069461 |
| 68 | Thyroiditis (HP:0100646) | 2.32570856 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.28294915 |
| 70 | Chronic otitis media (HP:0000389) | 2.26082138 |
| 71 | Gangrene (HP:0100758) | 2.25408520 |
| 72 | Lymphopenia (HP:0001888) | 2.23678277 |
| 73 | Chronic diarrhea (HP:0002028) | 2.23590739 |
| 74 | Colitis (HP:0002583) | 2.21614578 |
| 75 | Episodic fever (HP:0001954) | 2.20123765 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17363365 |
| 77 | Petechiae (HP:0000967) | 2.16702921 |
| 78 | IgM deficiency (HP:0002850) | 2.16459360 |
| 79 | Viral hepatitis (HP:0006562) | 2.12564031 |
| 80 | Sepsis (HP:0100806) | 2.10263554 |
| 81 | Combined immunodeficiency (HP:0005387) | 2.09102925 |
| 82 | Osteomyelitis (HP:0002754) | 2.05389726 |
| 83 | Papilledema (HP:0001085) | 2.04495783 |
| 84 | Keratitis (HP:0000491) | 2.03558337 |
| 85 | Prostate neoplasm (HP:0100787) | 2.00397647 |
| 86 | Verrucae (HP:0200043) | 1.96491923 |
| 87 | Papilloma (HP:0012740) | 1.96491923 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 1.95868312 |
| 89 | Hypoproteinemia (HP:0003075) | 1.94862855 |
| 90 | Vertigo (HP:0002321) | 1.94274390 |
| 91 | B lymphocytopenia (HP:0010976) | 1.93735522 |
| 92 | Acute hepatic failure (HP:0006554) | 1.88530203 |
| 93 | Abnormality of the peritoneum (HP:0002585) | 1.87507918 |
| 94 | Amaurosis fugax (HP:0100576) | 1.86626419 |
| 95 | Peritonitis (HP:0002586) | 1.86286361 |
| 96 | Thrombophlebitis (HP:0004418) | 1.84868154 |
| 97 | Abnormality of the endocardium (HP:0004306) | 1.84543974 |
| 98 | Hemiplegia (HP:0002301) | 1.83426356 |
| 99 | Glomerulopathy (HP:0100820) | 1.81976867 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81022377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.92926879 |
| 2 | MAP4K1 | 3.91783368 |
| 3 | TXK | 3.30432817 |
| 4 | BLK | 3.03875883 |
| 5 | FES | 2.97012521 |
| 6 | TAOK3 | 2.89454731 |
| 7 | MAP2K3 | 2.46903916 |
| 8 | TYK2 | 2.44431262 |
| 9 | CSK | 2.33637929 |
| 10 | IRAK4 | 2.26498659 |
| 11 | BTK | 2.25087421 |
| 12 | TEC | 2.21792014 |
| 13 | SYK | 2.20325363 |
| 14 | GRK6 | 2.17399345 |
| 15 | ZAP70 | 2.14018181 |
| 16 | JAK3 | 2.04951080 |
| 17 | ITK | 2.01412775 |
| 18 | FRK | 1.95784221 |
| 19 | MAP3K14 | 1.89180996 |
| 20 | TNK2 | 1.88592636 |
| 21 | KIT | 1.88393101 |
| 22 | IKBKE | 1.84169192 |
| 23 | HCK | 1.74473483 |
| 24 | MAP3K13 | 1.60861580 |
| 25 | LYN | 1.58989343 |
| 26 | JAK1 | 1.54709464 |
| 27 | LCK | 1.52460087 |
| 28 | CSF1R | 1.46423474 |
| 29 | NUAK1 | 1.39441596 |
| 30 | IKBKB | 1.29072294 |
| 31 | PIK3CG | 1.28221762 |
| 32 | JAK2 | 1.20165766 |
| 33 | TBK1 | 1.18643193 |
| 34 | CAMKK2 | 1.14569701 |
| 35 | IRAK1 | 1.11460324 |
| 36 | BMPR2 | 1.09986574 |
| 37 | MARK3 | 1.06260607 |
| 38 | FGR | 1.03387510 |
| 39 | FGFR3 | 1.03373616 |
| 40 | PRKCQ | 1.00785756 |
| 41 | ERN1 | 0.96203062 |
| 42 | TIE1 | 0.95819967 |
| 43 | MAP3K7 | 0.89277955 |
| 44 | MAP3K6 | 0.89034215 |
| 45 | YES1 | 0.87086028 |
| 46 | PTK2B | 0.86728927 |
| 47 | NLK | 0.84306902 |
| 48 | MATK | 0.82754215 |
| 49 | PRPF4B | 0.81637960 |
| 50 | MAPK7 | 0.81057302 |
| 51 | MAP3K11 | 0.79270070 |
| 52 | EPHB1 | 0.78984441 |
| 53 | TGFBR2 | 0.78619212 |
| 54 | MAP3K3 | 0.77651340 |
| 55 | STK10 | 0.77459793 |
| 56 | TAOK1 | 0.76413162 |
| 57 | KDR | 0.75508110 |
| 58 | ADRBK2 | 0.74833793 |
| 59 | PDK1 | 0.65258887 |
| 60 | MAP3K1 | 0.65173820 |
| 61 | SIK3 | 0.62028556 |
| 62 | EPHA3 | 0.61216149 |
| 63 | MAPK12 | 0.59555157 |
| 64 | FYN | 0.58944027 |
| 65 | MAP2K6 | 0.58463018 |
| 66 | PIM1 | 0.58316444 |
| 67 | CAMKK1 | 0.58282382 |
| 68 | STK11 | 0.56404758 |
| 69 | IRAK2 | 0.55162908 |
| 70 | CDK19 | 0.54216587 |
| 71 | HIPK2 | 0.52638571 |
| 72 | ACVR1B | 0.50307484 |
| 73 | PRKD2 | 0.49551445 |
| 74 | INSRR | 0.49070042 |
| 75 | PINK1 | 0.45550587 |
| 76 | GRK1 | 0.45477512 |
| 77 | DAPK2 | 0.45216814 |
| 78 | GRK7 | 0.44364663 |
| 79 | MAP3K5 | 0.44125403 |
| 80 | SGK2 | 0.40690754 |
| 81 | RPS6KA6 | 0.40386992 |
| 82 | MAP2K4 | 0.40386862 |
| 83 | PRKG2 | 0.38455983 |
| 84 | MAPK13 | 0.38359406 |
| 85 | ADRBK1 | 0.38225082 |
| 86 | MARK2 | 0.37609138 |
| 87 | ABL1 | 0.37442799 |
| 88 | RAF1 | 0.36416959 |
| 89 | CDK4 | 0.36077024 |
| 90 | RET | 0.33975345 |
| 91 | RPS6KL1 | 0.33156672 |
| 92 | RPS6KC1 | 0.33156672 |
| 93 | SGK3 | 0.31599588 |
| 94 | IGF1R | 0.31222081 |
| 95 | PTK6 | 0.30970546 |
| 96 | LRRK2 | 0.30399512 |
| 97 | KSR2 | 0.29196324 |
| 98 | SIK2 | 0.28916546 |
| 99 | PDPK1 | 0.28617586 |
| 100 | EGFR | 0.28192191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.27198496 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10841426 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.05211203 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90808053 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.89802055 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79691186 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46995361 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36241698 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35482843 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.35418737 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.32330142 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.26114668 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21924237 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11167257 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.03158786 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98706763 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.89895406 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.85248539 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82470834 |
| 20 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78098466 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70546667 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65630119 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62124367 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59134882 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55785093 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51494753 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.51237456 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50613947 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.48746905 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40924708 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39193927 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.37588451 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19452656 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15336614 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14112214 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13144596 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11853940 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.10719321 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06264117 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05563712 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03982545 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 0.97392774 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 0.95702827 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94378986 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87732288 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86755543 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.86505905 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81937181 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.79820411 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77402181 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77258821 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76401131 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67890016 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67273283 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66898773 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65453740 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65083372 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.64575325 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61883002 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60924871 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59114044 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57582827 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56357261 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55412771 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.55124022 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53972439 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53926241 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53349970 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48835433 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48354500 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47516007 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47485836 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46365439 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46055538 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42603896 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42558220 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42319867 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42093100 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41233107 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.40492600 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40128421 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39919867 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39421925 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38622384 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.38499223 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.36714532 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.36631112 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36607811 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36402338 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35219194 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30482246 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30073089 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30069158 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.30053039 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28742403 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28345974 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27441508 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26482481 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.26412061 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25228568 |

